Hospitalist perspectives on barriers to recommend and potential benefit of the COVID-19 vaccine

Sagar B. Dugani, Holly L. Geyer, Michael J. Maniaci, Karen M. Fischer, Ivana T. Croghan, Trevor J. Coons, Elizabeth L. Canan, M. Caroline Burton

Research output: Contribution to journalArticlepeer-review


Background: Hospitalists, comprised of nurse practitioners and physician assistants (collectively, advanced practice providers [APPs]) and physicians, have opportunities to counsel patients and reduce SARS-CoV-2 related coronavirus disease 2019 (COVID-19) vaccine hesitancy. However, hospitalist perspectives on the COVID-19 vaccine and potential differences between APPs and physicians are unknown. Understanding hospitalist perspectives could help to address vaccine hesitancy among patients. Methods: We conducted an online survey of hospitalists at Mayo Clinic sites in Arizona, Florida, Minnesota, and Wisconsin from 14 December 2020 through 4 January 2021. We collected demographic information and assessed perspectives on the COVID-19 vaccine and, for comparison, on the influenza vaccine. Descriptive statistics were used to compare responses between APPs and physicians. Results: The overall response rate was 42.7% (n = 128/300) and comprised of 53.9% women (n = 69/128) and 41.4% APPs (n = 53/128). Most hospitalists reported receiving or planning to receive vaccination against COVID-19 (93.7%; n = 119/128) and influenza (97.7%; n = 125/128). Most hospitalists reported they would advise 100% of patients to receive the COVID-19 vaccine (66% for APPs; 74.7% for physicians) and influenza vaccine (83% for APPs; 80% for physicians). Barriers to recommending the COVID-19 vaccine included patient health status and vaccine safety profile. Hospitalists reported that patients and coworkers receiving the COVID-19 vaccine would reduce their anxiety (~80% of hospitalists), social isolation (~64% of hospitalists), and improve their emotional support (~40% of hospitalists). APP and physician responses were similar. The possible reduction in social isolation was associated with higher odds of hospitalists advising all patients to receive the COVID-19 vaccine (adjusted odds ratio 2.95 [95% confidence interval, 1.32–6.59]; P< .008), whereas hospitalist age, gender, and profession showed no association. Conclusion: Most hospitalists would reportedly advise patients to receive the COVID-19 vaccine. Barriers to this recommendation included patient health status and vaccine safety. Hospitalists are an important resource to provide patient education and reduce COVID-19 vaccine hesitancy.

Original languageEnglish (US)
Pages (from-to)245-251
Number of pages7
JournalHospital Practice
Issue number4
StatePublished - 2021


  • COVID-19 infection
  • Hospital medicine
  • advanced practice providers
  • influenza vaccine
  • vaccine barriers
  • vaccine benefit

ASJC Scopus subject areas

  • Health Information Management
  • Medicine(all)
  • Clinical Biochemistry


Dive into the research topics of 'Hospitalist perspectives on barriers to recommend and potential benefit of the COVID-19 vaccine'. Together they form a unique fingerprint.

Cite this